ArticleFrontiers in medicine2025

Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system.

Yixuan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.